Medtronic announces first patient implants of investigational implantable tibial neuromodulation therapy for bladder incontinence
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study...
Source: prnewswire.com